跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 152 条关于
“AIHA”
全部
152
临床试验
100
药物
13
机构
0
资讯
39
7个月前
Rituxan Receives Japanese Approval for Autoimmune Hemolytic Anemia Treatment
去年
Low-Dose Rituximab Shows Transient Efficacy in Autoimmune Hemolytic Anemia
去年
BCMA-Targeted Bispecific Antibody CM336 Shows Promise for Refractory Autoimmune Hemolytic Anemia in NEJM Study
去年
Ouro Medicines Initiates Phase 1b Trial of OM336 in Autoimmune Cytopenias Following FDA Orphan Drug Designation
去年
FDA Grants Orphan Drug Designation to Sanofi's Rilzabrutinib for Autoimmune Hemolytic Anemia
9个月前
Ouro Medicines' Gamgertamig Receives Second FDA Orphan Drug Designation for Immune Thrombocytopenia
去年
Low-Dose Rituximab Trial Shows Limited Efficacy in Cold Agglutinin Disease Patients
8个月前
HUTCHMED's Sovleplenib Meets Primary Endpoint in Phase III Trial for Warm Autoimmune Hemolytic Anemia
5个月前
CAR-T Cell Therapy Achieves World-First Simultaneous Remission of Three Autoimmune Diseases
去年
Asha Therapeutics Receives ALS Association Grant for SARM1 Inhibitor ASHA-624
第 1 页,共 4 页
上一页
下一页